Japan Drugmaker Applies for Approval of Stem Cell-Derived Parkinson's Treatment; Aims to Obtain Approval Within FY25

parkinson
Sumitomo Pharma Co., a major drugmaker, announced on Tuesday that it has applied to the Health, Labor and Welfare Ministry for approval to produce and sell a regenerative medical product for the treatment of Parkinson’s disease.

New contents